Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study

Overview of attention for article published in Frontiers in endocrinology, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,205 followers.

A novel study that for the first time we showed the effect of SGLT2 against T2DM microvascular complications !

23 Jun 2022

Reply Repost Favourite

New Research: Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study: Aims This three-year follow-up study aimed to elucidate whether… https://t.co/m2F4W0lSgK #

17 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.